Eledon Pharmaceuticals, Inc. , clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant.
Eledon Pharmaceuticals stock last closed at $2.98, down 0.33% from the previous day, and has increased 47.52% in one year. It has overperformed other stocks in the Biotechnology industry by 1.25 percentage points. Eledon Pharmaceuticals stock is currently +56.02% from its 52-week low of $1.91, and -46.21% from its 52-week high of $5.54.
There are currently 59.88M shares of ELDN outstanding. The market capitalization of ELDN is $178.45M. In the past 24 hours, 107,324 ELDN shares were traded.
You need an online brokerage account to access the NASDAQ market and buy ELDN stock.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, you'll need to fill out some personal info so you are able to invest in ELDN stock today.
Now that you've finished signing up on one of the best stock market apps, you can securely and quickly fund your account:
Watch this video walkthrough for more details transferring funds into your brokerage account.
Once you have decided on the best place to buy Eledon Pharmaceuticals stock, it's crucial to research their stock prior to investing, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on ELDN's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge ELDN's intrinsic value.
Using relative valuations metrics:
You can do additional valuation analysis on ELDN's stock here.
Out of 1 sell side analysts who give ratings on ELDN, the consensus analyst rating on ELDN is a Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Eledon Pharmaceuticals stock forecast page.
In the last year, executives and large shareholders at ELDN have not bought or sold any shares.
Research more about who owns ELDN stock here.
No, Eledon Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two primary types of orders:
Click the Open Trade button and your broker will place your order.
If you require additional assistance buying stocks on eToro, watch the helpful video below:
Now that you own some ELDN shares, you'll want to stay up-to-date on your stock purchase.
Create a watchlist to get notified of important updates regarding your ELDN stock.
To reiterate, here are the 6 steps you need to take to buy Eledon Pharmaceuticals stock right now:
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep track of your investment in Eledon Pharmaceuticals, create your watchlist below.